Omics! Omics!

My father was a very methodical person, and that particularly applied when he decided to purchase the second IBM PC clone to appear on the m...

Last week news broke that Element Biosciences had won a patent lawsuit against Illumina, and that it affected MiSeq.  MiSeq????  How did a p...

A recent publication in Molecular Cell involving Fiber-Seq caught my attention, though I've since discovered this preprinted over a yea...

Okay, this is one of those cases where I kvetch about other people not having built the tools I want to use - perhaps a bit of a insufferabl...

I caught up by teleconference recently with Countable Labs CEO Giovanna Prout, fresh off Countable Labs' $26M equity fundraising - a rou...

An interesting news item this week is that BioNano Genomics has appointed Alex Hastie as Chief Scientific Officer.  Hastie is an obvious cho...

Another interesting preprint that fits several recent themes - genome minimization, discontinuation of products - comes from a Japanese grou...

There's an interesting new preprint from Jay Shendure's lab which introduces the technique of Shred-Seq, which is a Cas3-driven app...

Last week brought news that Standard Biotools, which is what Fluidigm morphed into, is being acquired by Treeline Biosciences, a drug develo...

Alexander Hoischen and colleagues have a brief piece in New England Journal of Medicine that published early this morning , in conjunction w...

The last bit of Craig Venter's career a followed, often a bit green with envy, was his work to build genomes.  This all revolved around ...

Few bombshells have hit genomics like the day in May 1998 when Craig Venter and Applied Biosystems announced he would be launching Celera Ge...

In the early 1990s, Craig Venter left the NIH over disputes around the patenting of ESTs.  Investors backed him, but then William Haseltine ...

I am overdue in getting back to my very personal review of how the recently passed J. Craig Venter made a huge impact on genomics science.  ...

The Festival of Genomics, Biodata and AI - thankfully known as FoG and not FogBA or FogBDA - will be at the Boston convention center this W...

Now to run through the long term technical projections from Oxford Nanopore's Tech Talk.  Well, projection is probably not the correct w...

I returned from London Calling 2026 much as I usually have - exhausted, more than a little hoarse, happy for discussions had and ruing conne...

My series on Craig Venter is on a small pause since I didn't get it out before I arrived here in London for Oxford Nanopore's annual...

Venter's big Expressed Sequence Tag - soon known as ESTs -  paper came out in June during my final summer as an intern; I photocopied it...

Craig Venter's sudden passing has triggered many writings about his life and work.  I'm overdue on my own personal reflections, and ...